Evidence map›Paper›PMID 30309840›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2018

Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.

Douglas M Silverstein, Scott O Trerotola, Timothy Clark, Garth James, Wing Ng, Amy Dwyer, Marius C Florescu, Roman Shingarev, Stephen R Ash, Kidney Health Initiative HDF Workgroup

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Surgical Referral for Hemodialysis Access Maintenance.Cardiovascular and interventional radiology · 2023
    Review
  13. Article
  14. The journal of vascular access · 2023
    Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Douglas M SilversteinCenter for Devices and Radiological Health, Division of Reproductive, Gastro-Renal, and Urological Devices, Renal Devices Branch, US Food and Drug Administration, Silver Spring, Maryland.
Scott O TrerotolaInterventional Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Timothy ClarkInterventional Radiology, Penn-Presbyterian Medical Center, Hospitals of the University of Pennsylvania, , Philadelphia, Pennsylvania.
Garth JamesCenter for Biofilm Engineering, Montana State University, Bozeman, Montana.
Wing NgRegulatory Affairs and Patient Recovery, Cardinal Health, Inc., Dublin, Ohio.
Amy DwyerInternal Medicine and Interventional Nephrology, University of Louisville, Louisville, Kentucky.
Marius C FlorescuInternal Medicine and Nephrology, University of Nebraska Medical Center, Omaha, Nebraska.
Roman ShingarevInternal Medicine and Nephrology, University of Alabama at Birmingham Medical Center, Birmingham, Alabama.
Stephen R AshIndiana University Health Arnett Hospital, Lafayette, Indiana.ORCID 0000-0003-4873-6087
Kidney Health Initiative HDF Workgroup

Funding

FDA HHS R18 FD005283
6 · The paper itself

Abstract

Central venous catheters remain a vital option for access for patients receiving maintenance hemodialysis. There are many important and evolving clinical and regulatory considerations for all stakeholders for these devices. Innovation and transparent and comprehensive regulatory review of these devices is essential to stimulate innovation to help promote better outcomes for patients receiving maintenance hemodialysis. A workgroup that included representatives from academia, industry, and the US Food and Drug Administration was convened to identify the major design considerations and clinical and regulatory challenges of central venous catheters for hemodialysis. Our intent is to foster improved understanding of these devices and provide the foundation for strategies to foster innovation of these devices.

Indexed as

Central Venous CathetersEquipment DesignHumansRenal DialysisRisk Assessmentchronic dialysisdialysis accessend stage kidney diseasehemodialysishemodialysis access

Identifiers

PMID30309840
PMCPMC6302318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.